dr. furman on the safety of acalabrutinib in hematologic malignancies
Published 4 years ago • 111 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
0:50
dr. furman on acalabrutinib monotherapy in cll
-
1:03
dr. woyach on the safety of acalabrutinib versus ibrutinib in cll
-
0:46
dr. furman on considering factors for upfront therapy in cll
-
1:56
dr. furman on exciting available agents for patients with cll
-
0:47
dr. furman on utility of prognostic markers in cll
-
2:02
the faces of mitochondrial disease
-
1:04:09
beware of inflammation: heart and brain at risk!
-
3:13
cll versus other leukemia types
-
1:15
dr. lampson on safety and efficacy of acalabrutinib, venetoclax, and obinutuzumab in cll
-
2:00
dr. barrientos discusses acalabrutinib in cll
-
7:13
using ibrutinib in chronic lymphocytic leukemia (cll)
-
1:41
dr. logan discusses acalabrutinib in cll
-
1:14
dr. davids on exciting data with acalabrutinib in cll
-
1:25
dr. abedin discusses differences between acalabrutinib and ibrutinib in cll
-
10:39
the effects and risks of alcohol on your body: what you need to know | dr. joel fuhrman
-
1:50
dr. mato on ibrutinib versus acalabrutinib in cll
-
1:14:56
ep 152 the 7 ts of massive hemorrhage protocols
-
1:16
dr. woyach on ibrutinib and peripheral lymphocytosis in patients with chronic lymphocytic leukemia
-
0:59
60-second sound-off: how biologics fundamentally changed clinical immunology
-
1:17
understanding motor apraxia: causes, symptoms, and effective therapies
-
12:50
that time a dude was given a nobel prize for intentionally infecting people with malaria
-
1:22
dr. awan on utilizing acalabrutinib in cll